Amryt Pharma Share Discussion Threads

[papillon] 02/10/2019 16:32

I could have made a mistake, volsung. I'll probably buy the 500 back (plus a few more) in a few weeks time, hopefully at a lower price.

[volsung] 02/10/2019 16:25

Got around that number myself pap. A profits a profit

[papillon] 02/10/2019 16:24

I sold a few this morning, volsung. Just 500 @ 126.02p per share. If I had got up earlier I might have got a better price! Now got 4,500. Keeping them. Taken a view this could fall further in the short term based on the chart, bwtfdik? Made a small profit (around 20p per share) as I bought them at the end of August.

[volsung] 02/10/2019 14:27

Bought a few more on this dip

[papillon] 01/10/2019 12:40

8 trades so far today and all small sells. HOWEVER there were 4 large trades (all over £30k in value) from Friday reported well after the market closed last night. The strange trading pattern and reporting behaviour continues with AMYT. What can it all mean?

[bermudashorts] 01/10/2019 07:24

AP101 has been granted FDA Fast Track Designation - excellent news.

IF (note use of capital letters) the EASE trial is successful this could potentially could save months and months when it comes to review of the NDA . Of course this is on top of the Pediatric Rare Disease designation (and the valuable Priority Review Voucher) already awarded by the FDA back in August last year.

Good stuff.

[papillon] 30/9/2019 17:05

They've just been released, kfp. After the market closed at 4:30pm! Unusual! Not that these interim results mean much because "new" AMYT is a completely different animal to the "old" AMYT for which these results refer.

There were just 10 trades today. All small sells.

[kfp] 30/9/2019 08:30

Anyone know next results date ?
I thought it was today ?

[papillon] 27/9/2019 18:39

Two big trades from yesterday and reported after the market closed today. One for 50k shares @ 133p (£66.5k) and timed @ 11:34:48 yesterday and the next for 65k shares @ 134p (£87.1k) and timed @ 11:35:25 yesterday.

The lse web site has the first trade as unknown and the second as a buy based on today's closing price spread (131-135p). Looking at the trades timed between 11am and 1:45pm yesterday and reported then they were all sells (3 in total) and the selling price in every case was 132p (the quoted spread then was 131-135p). Hence I feel it's safe to assume that both of these large trades yesterday whose reporting was delayed until after market close today were, in fact, buys.

The share price has been going sideways all week. I'm expecting a further rise in the share price and soon.

[macc1] 26/9/2019 16:37

Hi all,

posting a bit late, but here's a video covering yesterdays announcement with the CEO Joe Wiley. Also a bit more about the business.

[papillon] 26/9/2019 15:56

Okay, sidam. I believe you. Ignore my post last night.

I have no idea whether AP101 will be successful, or not, sidam. Like mdalos I originally bought shares in FAST at just over 2p back in early 2015 (there has been a 1 for 8 and a further I for 6 consolidation since then so the equivalent share price today would be just over 2p x 8 x 6 = 96p, say £1).

I had a bad experience with a biotech over 15 years ago (Xenova : XEN) so I've always steered well clear of them. However I stuck with AMYT following the RTO back in 2016 and even added in my own small way before dumping most of my AMYT shares early this year following the AP101 trial news, keeping just a token few hundred pounds worth. I made next to nothing in the way of profit.

I then bought back in so I ended up with around £2.8k's worth, just prior to the May suspension, thinking that the company was cheap considering it still had the growing Lojuxta revenue and the possibility of a big winner in AP101, plus AP103.

With the benefit of hindsight I'm glad I did buy back in though I did have initial misgivings about the Aegerion RTO which I don't believe any poster on this bb could ever have anticipated.

I'm hopeful, bearing in mind the proposed Nasdaq listing and the contents of the Mark Taub article, that the AMYT share price could be above £2 by the time the result of the AP101 Phase III trial is known (fingers crossed). Obviously the AP101 result will have an effect on the AMYT sp, but nowhere near to the same effect it would have had on the "OLD" AMYT share price

PS The good news is the new AMYT share price hasn't collapsed after the CVR's are no longer available to the buyer, which I had thought possible. I believe mdalos thought the share price would collapse.

[sidam] 26/9/2019 14:30

Papillon
I assure you that I was not taking the pxxx. I am studying French in my old age so it came naturally. No other comment required.

If you go back to a very early post of mine, you will see that on a DCF basis I thought AP101 could be conservatively valued at £500m. Caveat it got approval.

So I hope we both make loads of lolly.

[papillon] 26/9/2019 11:54

I know that papillon is French for butterfly, sidam and I remember the early 70's film of that name well. However I'm convinced you were taking the p*ss by calling me butterfly instead of papillon. Still it's not important.

[sidam] 25/9/2019 22:49

Papillon please except my humble apologies, if my French translation has upset you so much. Given that a really well known actor played the part I thought you might have taken it as a compliment.

[delta0091] 25/9/2019 20:03

"Did they mean that you had to be on the register, but could have sold early in the day."

you must have held the stock at close of Friday.

[alphabravo321] 25/9/2019 18:40

Maybe cagey is the wrong word, I meant he looked like he knew something he was uncomfortable sharing, in a positive sense

[bageo] 25/9/2019 18:36

Good interview, thanks for the link Bermudashorts.

alphabravo - I don't think his answer on nasdaq was cagey. He didn't answer "yes ... part of short term plans" to the nasdaq question which would have been the simple answer if true. He answered "a US listing" "part of short term plans" therefore he has kept the options open for himself which is sensible.

[bageo] 25/9/2019 18:32

Surely it depends on what your dealing terms are - T20, T2 or something else. When you are registered as the owner rather than the transaction date is the critical one.
This is consistent with documentation and xd dates or similar from other companies.

[sidam] 25/9/2019 17:11

Delta

Thanks for that maybe it is semantics, but the company said that you must hold the shares at close of play on Friday to get the CVRs. Did they mean that you had to be on the register, but could have sold early in the day.

Normally, I would have expected that the buyer could claim the CVRs.

However, I called the nomad and he said that the registrars took a copy of the register in the evening and those on it get the CVRs and buyers can’t claim them.

So butterfly’s enemy seems to be much cleverer than the rest of us.

I am going to make an official complaint as that is not correct by precedent.

[volsung] 25/9/2019 16:26

What happens if your stock is held in a SIPP? Do you still get CVRs. I've held these for a year or so now

[papillon] 25/9/2019 16:25

sp has held up well today.